Cardiff Oncology, Inc.·4

Jul 1, 4:09 PM ET

Mohindru Mani 4

4 · Cardiff Oncology, Inc. · Filed Jul 1, 2024

Insider Transaction Report

Form 4
Period: 2024-06-27
Mohindru Mani
DirectorInterim CEO
Transactions
  • Award

    Stock Options

    2024-06-27+29,700128,201 total
    Exercise: $2.33From: 2025-06-27Exp: 2034-06-27Common Stock (29,700 underlying)

Documents

1 file
  • 4
    wk-form4_1719864546.xmlPrimary

    FORM 4